Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor

por Küsters-Vandevelde, Heidi VN, Willemsen, Annelieke ECAB, Groenen, Patricia JTA, Küsters, Benno, Lammens, Martin, Wesseling, Pieter, Djafarihamedani, Melika, Rijntjes, Jos, Delye, Hans, Willemsen, Michel A, van Herpen, Carla ML, Blokx, Willeke AM
Publicado 2014

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome

por Reijnen, Casper, Küsters‐Vandevelde, Heidi V.N., Ligtenberg, Marjolijn J.L., Bulten, Johan, Oosterwegel, Marloes, Snijders, Marc P.L.M., Sweegers, Sanne, de Hullu, Joanne A., Vos, Maria C., van der Wurff, Anneke A.M., van Altena, Anne M., Eijkelenboom, Astrid, Pijnenborg, Johanna M.A.
Publicado 2020

Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer

por van Bommel, Majke H.D., Pijnenborg, Johanna M.A., van der Putten, Louis J M, Bulten, Johan, Snijders, Marc P.L.M., Küsters-Vandevelde, Heidi V.N., Sweegers, Sanne, Vos, M. Caroline, Ligtenberg, Marjolein J.L., Eijkelenboom, Astrid, de Hullu, Joanne A, Reijnen, Casper
Publicado 2022